A specialty pharmaceutical business focused on developing and commercializing therapies for chronic pain and related conditions, particularly opioid-based and opioid‑adjacent treatments. Its portfolio included products such as BELBUCA, a buccal film formulation of buprenorphine for long‑term pain ma...
1 member of Congress has disclosed 3 trades in BioDelivery Sciences International Incorporated (BDSI), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 2 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2016-06-22 | Adam B. Schiff | sell | $15K – $50K |
| 2016-05-09 | Adam B. Schiff | buy | $15K – $50K |
| 2016-04-25 | Adam B. Schiff | sell | $1K – $15K |